N95 Mask (fm-3g)

Basic information

Product Description:
The EarlyTect Colon Cancer Test is a highly reliable and clinically-approved product for the detection of colorectal cancer. This test has undergone rigorous clinical trials at reputable medical centers, including Yonsei Medical Center, Severance Hospital, and Severance Check-up Center, with 585 eligible subjects aged 30 to 80. Through these trials, it has been proven that this test can diagnose colorectal cancer with an impressive sensitivity and specificity rate of 90%.

Utilizing fecal DNA analysis, the EarlyTect Colon Cancer Test employs a qualitative real-time PCR method to measure methylated Syndecan-2, a biomarker that is directly related to the detection of precancerous lesions in colorectal cancer. It is important to note that this test is not intended to provide a definitive diagnosis of colorectal cancer. However, a positive result indicates the potential presence of colorectal cancer or its precancerous lesions.

Product Standard:
- Cancer Type: Colorectal Cancer
- Subject: Asymptomatic individuals undergoing colorectal cancer screening
- Biomarker: SDC2 methylation

The pricing and transaction conditions for the EarlyTect Colon Cancer Test are negotiable. To inquire about the price and initiate a transaction, please request a quote.